In Situ Hybridization Global Market Report 2026

In-situ hybridization is a method that facilitates the precise localization of a specific nucleic acid segment within a histologic slice. This technique is employed for identifying sequences of nucleotides in tissues, encompassing complete tissues, portions of tissues, and individual cells.

The primary types of in-situ hybridization products include analytical instruments, kits and reagents, software and services, among others. Analytical instruments are designed to assist researchers in detecting and visualizing specific nucleic acid sequences within cells or tissues. Various techniques involved in this process include fluorescence in situ hybridization (FISH) and chromogenic in situ hybridization (CISH), which utilize different types of probes such as DNA and RNA. These techniques find applications in diverse areas, including cancer research, cytogenetics, developmental biology, infectious diseases, and more. The end users of these products include research and diagnostic laboratories, contract research organizations (CROs), academic institutes, and others.

Tariffs are impacting the in situ hybridization market by increasing costs of imported microscopes, imaging systems, probes, reagents, and analytical software used in FISH and CISH workflows. Research laboratories and diagnostic centers in North America and Europe are most affected due to reliance on imported laboratory equipment, while Asia-Pacific faces higher costs in reagent manufacturing and exports. These tariffs are increasing operational expenses and slowing laboratory upgrades. However, they are also encouraging local reagent production, regional instrument assembly, and development of cost-effective hybridization solutions.

The in situ hybridization market research report is one of a series of new reports from The Business Research Company that provides in situ hybridization market statistics, including in situ hybridization industry global market size, regional shares, competitors with a in situ hybridization market share, detailed in situ hybridization market segments, market trends and opportunities, and any further data you may need to thrive in the in situ hybridization industry. This in situ hybridization market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The in situ hybridization market size has grown rapidly in recent years. It will grow from $1.81 billion in 2025 to $2.01 billion in 2026 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to expansion of molecular pathology research, increasing cancer diagnostics demand, growth in cytogenetic testing applications, availability of advanced laboratory infrastructure, rising adoption of FISH techniques.

The in situ hybridization market size is expected to see rapid growth in the next few years. It will grow to $3.08 billion in 2030 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to increasing demand for personalized medicine diagnostics, rising integration of AI-based image analysis, expansion of companion diagnostics applications, growing investments in genomic research, increasing use of in situ hybridization in infectious disease detection. Major trends in the forecast period include increasing adoption of fluorescence-based hybridization techniques, rising demand for molecular diagnostic accuracy, growing use of automated imaging and analysis systems, expansion of cancer diagnostic applications, enhanced integration of digital pathology tools.

The rise in infectious diseases is projected to drive the growth of the in-situ hybridization market in the coming years. Infectious diseases are conditions that can be transmitted from one person to another through contaminated food and beverages, as well as through pathogens such as viruses, bacteria, fungi, and parasites. In situ hybridization (ISH) aims to detect complementary nucleic acid sequences in tissue samples by using labeled nucleic acid sequences (probes) that are specific to the infectious organism. Thus, a rise in infectious diseases contributes to the expansion of the in-situ hybridization market. For example, in March 2024, the Centers for Disease Control and Prevention (CDC), a U.S.-based government agency, reported that tuberculosis cases increased from 8,320 in 2022 to 9,615 in 2023, representing a rise of 1,295 cases. Therefore, the growing prevalence of infectious diseases is fueling the growth of the in-situ hybridization market.

Major companies operating in the in-situ hybridization market are driving profitability through innovative product solutions, such as Hybridization Chain Reaction RNA Chromogenic in situ Hybridization (HCR RNA-CISH). HCR RNA-CISH is a technique that facilitates the visualization of RNA molecules in cells and tissues with high resolution and sensitivity. In February 2023, Molecular Instruments (MI) launched HCR RNA-CISH to enhance automated chromogenic in-situ hybridization workflows, providing better performance than existing approaches with reduced turnaround time and cost. It also features native support for Immunohistochemistry (IHC) codetection and full compatibility with major automation platforms.

In December 2023, Danaher Corporation, a US-based global life sciences and diagnostics company, acquired Abcam plc for approximately US$5.7 billion. With this acquisition, Danaher aims to broaden its diagnostics and reagents portfolio and strengthen its molecular assay development capabilities by incorporating Abcam's wide range of antibodies, kits, and research reagents. Abcam plc is a UK-based life sciences tools company recognized for providing high-quality reagents and assay products used across molecular biology workflows, including applications that support in situ hybridization and immunohistochemistry.

Major companies operating in the in situ hybridization market are Thermo Fisher Scientific Inc., Bio SB Inc., BioGenex Laboratories, Advanced Cell Diagnostics Inc., Exiqon A/S, Agilent Technologies Inc., F. Hoffmann-La Roche AG, Abbott Laboratories Inc., Merck KGaA, PerkinElmer Inc., Biocare Medical LLC, Genemed Biotechnologies, Danaher Corporation, Leica Biosystems Nussloch GmbH, Bio-Rad Laboratories Inc., Oxford Gene Technology, Qiagen, Bio-Techne Corporation, Cytocell Ltd., Enzo Life Sciences Inc., Eurofins Scientific SE, Zytomed System GmbH, Akoya Biosciences Inc., Becton Dickinson and Company (BD), DAKO Systemtechnik und Service GmbH & Co, NanoString Technologies Inc., Visiopharm A/S

North America was the largest region in the in situ hybridization market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global in situ hybridization market during the forecast period. The regions covered in the in situ hybridization market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the in situ hybridization market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The In-situ hybridization market includes revenues earned by entities by providing in-situ hybridization with synthetic oligonucleotides probes, double-stranded DNA (dsDNA) probes, and single-stranded DNA (dsDNA) probes. The market value includes the value of related goods sold by the service provider or included within the service offering. The In-situ hybridization market also includes sales of linear hybridization chain reaction techniques and non-linear hybridization chain reaction techniques. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In Situ Hybridization Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses in situ hybridization market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in situ hybridization ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The in situ hybridization market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Analytical Instruments; Kits and Reagents; Software and Services
• 2) By Technique: Fluorescence In Situ Hybridization (FISH); Chromogenic In Situ Hybridization (CISH)
• 3) By Probe: Deoxyribonucleic Acid (DNA); Ribonucleic Acid (RNA)
• 4) By Application: Cancer; Cytogenetics; Developmental Biology; Infectious Diseases
• 5) By End Use: Research And Diagnostic Laboratories; Contract Research Organization (CROs); Academic Institutes
• Subsegments:
• 1) By Analytical Instruments: Fluorescence Microscopes; Imaging Systems; Hybridization Systems
• 2) By Kits and Reagents: Hybridization Kits; Detection Kits; Probes And Reagents
• 3) By Software and Services: Image Analysis Software; Data Management Software; Consulting And Support Services
• Companies Mentioned: Thermo Fisher Scientific Inc.; Bio SB Inc.; BioGenex Laboratories; Advanced Cell Diagnostics Inc.; Exiqon A/S; Agilent Technologies Inc.; F. Hoffmann-La Roche AG; Abbott Laboratories Inc.; Merck KGaA; PerkinElmer Inc.; Biocare Medical LLC; Genemed Biotechnologies; Danaher Corporation; Leica Biosystems Nussloch GmbH; Bio-Rad Laboratories Inc.; Oxford Gene Technology; Qiagen; Bio-Techne Corporation; Cytocell Ltd.; Enzo Life Sciences Inc.; Eurofins Scientific SE; Zytomed System GmbH; Akoya Biosciences Inc.; Becton Dickinson and Company (BD); DAKO Systemtechnik und Service GmbH & Co; NanoString Technologies Inc.; Visiopharm A/S
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.